[{"NetIncomeLoss_2_Q2_USD":-19512000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37902294.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":42936991.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":8117000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":3027000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":282000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.908,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.908,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":25000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":7229000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.016,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.005,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-76606000.0,"Depreciation_2_Q2_USD":500000.0,"Depreciation_1_Q2_USD":300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1389476.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":819000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":353000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1588000.0,"AssetsCurrent_0_Q2_USD":160563000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4497483.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4497483.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1542000.0,"CommonStockSharesIssued_0_Q2_shares":45826798.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":157275000.0,"Assets_0_Q2_USD":168323000.0,"ShareBasedCompensation_2_Q2_USD":2392000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3576000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":22.85,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"GeneralAndAdministrativeExpense_1_Q2_USD":2705000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"GeneralAndAdministrativeExpense_2_Q2_USD":5726000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":14605000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7148000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":6.09,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":7483000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-20000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":37902294.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":42936991.0,"PrepaidExpenseCurrent_0_Q2_USD":1780000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":46000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":1684000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":731000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":157002000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":97363000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":1000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":67284000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":3793706.0,"OtherAssetsCurrent_0_Q2_USD":1312000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-19291000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-9353000.0,"OtherAssetsNoncurrent_0_Q2_USD":282000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":17296000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4960000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":262041000.0,"Liabilities_0_Q2_USD":10005000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":241000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":50000.0,"OperatingLeaseLiability_0_Q2_USD":5929000.0,"MarketableSecuritiesCurrent_0_Q2_USD":140175000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1554000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1635000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":166000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":143780000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2307000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":221000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":147000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1219000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-20000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":97000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-18392000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":157275000.0,"LiabilitiesCurrent_0_Q2_USD":5045000.0,"AccountsPayableCurrent_0_Q2_USD":1007000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":17296000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":128000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.838,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.881,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":174000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.1,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":3087000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.004,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.004,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":6000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"OperatingLeasePayments_2_Q2_USD":435000.0,"OperatingLeasePayments_1_Q2_USD":224000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3902000.0,"NetIncomeLoss_1_Q2_USD":-9500000.0,"CommonStockSharesOutstanding_0_Q2_shares":45826798.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":2345000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-103794000.0,"VariableLeaseCost_1_Q2_USD":81000.0,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"OperatingIncomeLoss_2_Q2_USD":-20331000.0,"OperatingIncomeLoss_1_Q2_USD":-9853000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":22000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.76,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.9,"OperatingLeaseCost_2_Q2_USD":550000.0,"OperatingLeaseCost_1_Q2_USD":275000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":168323000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":973000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2392000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1219000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":752000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":12500.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":969000.0,"OperatingExpenses_2_Q2_USD":20331000.0,"OperatingExpenses_1_Q2_USD":9853000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.22,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.51,"ProfitLoss_2_Q2_USD":-19512000.0,"OtherLiabilitiesCurrent_0_Q2_USD":42000.0,"StockholdersEquity_0_Q2_USD":158318000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":110000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":157002000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":183000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4478042.0,"VariableLeaseCost_2_Q2_USD":212000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":6209000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":296000.0,"Ticker":"KZR","CIK":"1645666","name":"KEZAR LIFE SCIENCES, INC.","OfficialName":"Kezar Life Sciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"829139908.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]